A trio of top officials overseeing the fledgling medical cannabis program in Missouri have been subject to questioning by the Federal Bureau of Investigation.
The Kansas City Star reported Wednesday that the three officials, all members of Republican Gov. Mike Parson’s administration, described the interviews, which took place over the last several months, as “not investigative in nature,” but rather “routine meet-and-greets the FBI requested to get to know the people in charge of the new — and potentially lucrative — industry.”
Missouri voters approved Amendment 2 last November to legalize medical marijuana by a massive 66%-34% margin, joining more than 30 other states that have legalized the treatment. Under the new law, physicians can prescribe cannabis to patients suffering from 10 different medical conditions, which include cancer, epilepsy and glaucoma, among other debilitating illnesses. Missouri’s Department of Health and Senior Services (DHSS) began accepting applications for such prescriptions late last month. Qualifying patients will receive an identification card, which will enable them to purchase up to four ounces of marijuana per month.
Although the interviews between the FBI and the Missouri officials were routine in nature, they do underscore the unique status of marijuana in the country. While cannabis